These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8161719)

  • 41. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative bioavailability of 875 mg amoxicillin tablets in healthy human volunteers.
    Baglie S; Rosalen PL; Franco LM; Ruenis AP; Baglie RC; Franco GC; Silva P; Groppo FC
    Int J Clin Pharmacol Ther; 2005 Jul; 43(7):350-4. PubMed ID: 16035378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
    Bonn M; Eydeler U; Barkworth M; Rovati LC
    Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
    Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioavailability and pharmacokinetic profile of dihydroergotoxine from a tablet and from an oral solution formulation.
    Setnikar I; Schmid K; Rovati LC; Vens-Cappell B; Mazur D; Kozak I
    Arzneimittelforschung; 2001 Jan; 51(1):2-6. PubMed ID: 11215321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs.
    Baxter JG; Brass C; Schentag JJ; Slaughter RL
    J Pharm Sci; 1986 May; 75(5):443-7. PubMed ID: 3735080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine.
    Yuen GJ; Morris DM; Mydlow PK; Haidar S; Hall ST; Hussey EK
    J Clin Pharmacol; 1995 Dec; 35(12):1174-80. PubMed ID: 8750368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and relative bioavailability after single dose administration of 25 mg ketoprofen solution as compared to tablets.
    Stiegler S; Birkel M; Jost V; Lange R; Lücker PW; Wetzelsberger N
    Methods Find Exp Clin Pharmacol; 1995 Mar; 17(2):129-34. PubMed ID: 7674700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
    Kölle EU; Vollmer KO
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers.
    Gascón AR; Cuadrado A; Solinís MA; Hernández RM; Ramírez E; Dalmau R; Pedraz JL
    Int J Clin Pharmacol Ther; 2003 Jul; 41(7):309-15. PubMed ID: 12875347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
    Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation.
    Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative bioavailability of three cefixime formulations.
    Kees F; Naber KG; Sigl G; Ungethüm W; Grobecker H
    Arzneimittelforschung; 1990 Mar; 40(3):293-7. PubMed ID: 2346538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of thermosensitive liposome-containing in-situ gel systems for intranasal administration of thiocolchicoside and in vivo evaluation in a rabbit model.
    Uner B; Baranauskaite Ortasoz J; Tas C
    Pharm Dev Technol; 2024 Jul; 29(6):582-595. PubMed ID: 38841795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.
    Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL
    Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects.
    Holazo AA; Colburn WA; Gustafson JH; Young RL; Parsonnet M
    J Pharm Sci; 1984 Aug; 73(8):1108-13. PubMed ID: 6491914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [RU 28965, a new semi-synthetic macrolide. Bioavailability and pharmacokinetic profile after oral administration].
    Tremblay D; Bryskier A; Vuckovic M; Stockis A; Manuel C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):502-6. PubMed ID: 3911143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.